Basit öğe kaydını göster

Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.

dc.contributor.authorRay, Kausik K
dc.contributor.authorInzucchi, Silvio E
dc.contributor.authorKosiborod, Mikhail N
dc.contributor.authorCherney, David Z I
dc.contributor.authorDwyer, Jamie P
dc.contributor.authorScirica, Benjamin M
dc.contributor.authorBailey, Clifford J
dc.contributor.authorDíaz, Rafael
dc.contributor.authorUdell, Jacob A
dc.contributor.authorSteg, P Gabriel
dc.contributor.authorLapuerta, Pablo
dc.contributor.authorLopes, Renato D
dc.contributor.authorBhatt, Deepak L
dc.contributor.authorSzarek, Michael
dc.contributor.authorPitt, Bertram
dc.contributor.authorCannon, Christopher P
dc.contributor.authorLeiter, Lawrence A
dc.contributor.authorMcGuire, Darren K
dc.contributor.authorLewis, Julia B
dc.contributor.authorRiddle, Matthew C
dc.date.accessioned2021-03-02T15:37:48Z
dc.date.available2021-03-02T15:37:48Z
dc.identifier.citationBhatt D. L. , Szarek M., Pitt B., Cannon C. P. , Leiter L. A. , McGuire D. K. , Lewis J. B. , Riddle M. C. , Inzucchi S. E. , Kosiborod M. N. , et al., "Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.", The New England journal of medicine, cilt.384, ss.129-139, 2021
dc.identifier.issn0028-4793
dc.identifier.othervv_1032021
dc.identifier.otherav_6d29b619-2be2-45b3-b5d6-39609cae8e6c
dc.identifier.urihttp://hdl.handle.net/20.500.12627/1565
dc.identifier.urihttps://doi.org/10.1056/nejmoa2030186
dc.language.isoeng
dc.titleSotagliflozin in Patients with Diabetes and Chronic Kidney Disease.
dc.typeMakale
dc.relation.journalThe New England journal of medicine
dc.contributor.departmentİstanbul Üniversitesi , İstanbul Tıp Fak , İst Tıp Fak
dc.identifier.volume384
dc.identifier.startpage129
dc.identifier.endpage139
dc.contributor.firstauthorID2505373


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster